Assay Detail
Binding
CHEMBL5230720
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of CDK9 (unknown origin)
8
Total Activities
8
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Publication
A comprehensive insight on the recent development of Cyclic Dependent Kinase inhibitors as anticancer agents.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 8 | 7.92 | 8.40 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL2103840 | DINACICLIB | 3.0 | 1 | 8.40 |
| CHEMBL5273925 | — | — | 1 | 8.40 |
| CHEMBL445813 | AT-7519 | 2.0 | 1 | 8.00 |
| CHEMBL428690 | ALVOCIDIB | 3.0 | 1 | 7.70 |
| CHEMBL488436 | AZD-5438 | 1.0 | 1 | 7.70 |
| CHEMBL3991935 | — | — | 1 | 7.70 |
| CHEMBL3904602 | LEROCICLIB | 3.0 | 1 | 7.55 |
| CHEMBL4462530 | ZEMIRCICLIB | 2.0 | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL2103840 | DINACICLIB | IC50 | = | 4.0 | nM | 8.40 |
| CHEMBL5273925 | — | IC50 | = | 4.0 | nM | 8.40 |
| CHEMBL445813 | AT-7519 | IC50 | = | 10.0 | nM | 8.00 |
| CHEMBL428690 | ALVOCIDIB | IC50 | = | 20.0 | nM | 7.70 |
| CHEMBL488436 | AZD-5438 | IC50 | = | 20.0 | nM | 7.70 |
| CHEMBL3991935 | — | IC50 | = | 20.0 | nM | 7.70 |
| CHEMBL3904602 | LEROCICLIB | IC50 | = | 28.0 | nM | 7.55 |
| CHEMBL4462530 | ZEMIRCICLIB | IC50 | < | 4.0 | nM | - |